Back to Conference Homepage
Back to Conference Faculty List
Back to Conference Schedule
Presentation Title: Lung Cancer and Tobacco Cessation
Dr. Ou will review ways for physicians to help their patients stop smoking and summarize developments in lung cancer screening.
Time: Sunday Morning
Purpose:
To improve on clinical competence and performance in tobacco cessation
Objectives:
- Utilize recent clinical evidence and guidelines for lung cancer screening
- Implement lung cancer screening for appropriate patients
- Incorporate the five "A's" Public Health Service guidelines (Ask, Advise, Assess, Assist, and Arrange) on tobacco cessation
- Educate patients on the benefit of smoking cessation
- Incorporate the use of electronic health records to imrpove on tobacco cessation
Current Positions:
Health Science Associate Professor of Medicine; Adjunct Assistant Professor of Epidemiology, UCI School of Medicine
Sai-Hong Ignatius Ou (吴 世 康) MD PhD is an Associate Clinical Professor in Hematology–Oncology at the Chao Family Comprehensive Cancer Center, University of California Irvine. He specializes in treating upper aerodigestive tract malignancies (Lung, Head and Neck, Thyroid, Esophageal, and Stomach cancer). He received his BA from the University of California Berkeley, his MD and PhD degrees from the University of Texas Southwestern Medical School in Dallas, his medicine residency training at Duke University Medical Center, and his hematology-oncology fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston. His research is focus on the epidemiology on the ethnic differences in lung cancer especially among never-smokers and other upper aerodigestive malignancies and is involved in active collaborations with other cancer registries in Asia. He is also involved in many clinical trials involving novel targeted therapies in lung cancer especially NSCLC with ALK translocation. He is also the Institutional Principal Investigator of the Southwest Oncology Group (SWOG) at UC Irvine.